Clinical Trials Directory

Trials / Completed

CompletedNCT04969653

The Incidence of Venous Thromboembolism in Atopic Dermatitis

The Incidence of Venous Thromboembolism in Atopic Dermatitis: A Matched Cohort Analysis in UK Primary Care

Status
Completed
Phase
Study type
Observational
Enrollment
754,745 (actual)
Sponsor
Momentum Data · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study aims to investigate the incidence of venous thromboembolism in people who are diagnosed with atopic dermatitis.

Detailed description

The aim of this study is to examine whether venous thromboembolism is higher in people with atopic dermatitis compared and those without and to explore the risk in particular subgroups of people with AD such as those with higher body mass index or using oestrogen containing contraceptives. Such insights will be valuable for clinicians in advising patients with atopic dermatitis regarding venous thromboembolism prevention and detection and when selecting atopic dermatitis treatments.

Conditions

Interventions

TypeNameDescription
OTHERExposure of venous thromboembolismComposite of pulmonary embolism and deep vein thrombosis

Timeline

Start date
2021-06-21
Primary completion
2023-03-31
Completion
2023-07-01
First posted
2021-07-21
Last updated
2024-12-09
Results posted
2024-12-09

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04969653. Inclusion in this directory is not an endorsement.